Brown WV - Search Results

1

Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.

Brown WV, Bays HE, Hassman DR, McKenney J, Chitra R, Hutchinson H, Miller E; Rosuvastatin Study Group. Brown WV, et al. Am Heart J. 2002 Dec;144(6):1036-43. doi: 10.1067/mhj.2002.129312. Am Heart J. 2002. PMID: 12486428 Clinical Trial.

2

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups.

Blasetto JW, Stein EA, Brown WV, Chitra R, Raza A. Blasetto JW, et al. Among authors: brown wv. Am J Cardiol. 2003 Mar 6;91(5A):3C-10C; discussion 10C. doi: 10.1016/s0002-9149(03)00003-1. Am J Cardiol. 2003. PMID: 12646336 Clinical Trial.

3

Planning a clinical trial.

Brown WV, Bays HE, Maki KC, Wild RA. Brown WV, et al. J Clin Lipidol. 2012 Nov-Dec;6(6):484-95. doi: 10.1016/j.jacl.2012.10.001. Epub 2012 Oct 5. J Clin Lipidol. 2012. PMID: 23312046 Review. No abstract available.

4

National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.

Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP, Brown WV. Jacobson TA, et al. Among authors: brown wv. J Clin Lipidol. 2014 Sep-Oct;8(5):473-88. doi: 10.1016/j.jacl.2014.07.007. Epub 2014 Jul 15. J Clin Lipidol. 2014. PMID: 25234560 Free article.

5

National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.

Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP, Brown WV. Jacobson TA, et al. Among authors: brown wv. J Clin Lipidol. 2015 Mar-Apr;9(2):129-69. doi: 10.1016/j.jacl.2015.02.003. Epub 2015 Apr 7. J Clin Lipidol. 2015. PMID: 25911072

6

JCL roundtable: PCSK9 inhibitors in clinical practice.

Brown WV, Moriarty PM, McKenney JM. Brown WV, et al. J Clin Lipidol. 2016 Jan-Feb;10(1):5-14. doi: 10.1016/j.jacl.2015.12.004. Epub 2015 Dec 12. J Clin Lipidol. 2016. PMID: 26892118

7

Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy.

Toth PP, Bays HE, Brown WV, Catapano AL, Davidson MH, Farnier M, Tomassini JE, Jensen E, Polis AB, Tershakovec AM. Toth PP, et al. Among authors: brown wv. J Clin Lipidol. 2019 Nov-Dec;13(6):997-1007.e8. doi: 10.1016/j.jacl.2019.09.001. Epub 2019 Sep 11. J Clin Lipidol. 2019. PMID: 31629703

8

National survey of pharmacists about coronary heart disease, hypercholesterolemia, nonprescription statintherapy, and pharmacists' services.

McKenney JM, Bradberry JC, Talbert RL, Cahill E, Brown WV. McKenney JM, et al. Among authors: brown wv. J Am Pharm Assoc (2003). 2004 Sep-Oct;44(5):562-8. doi: 10.1331/1544-3191.44.5.562.mckenney. J Am Pharm Assoc (2003). 2004. PMID: 15496041

9

JCL roundtable: lipid-lowering drugs in those older than 75 years of age.

Brown WV, Bittner VA, McKenney JM, Ziajka PE. Brown WV, et al. J Clin Lipidol. 2014 Nov-Dec;8(6):533-541. doi: 10.1016/j.jacl.2014.09.009. Epub 2014 Sep 28. J Clin Lipidol. 2014. PMID: 25499934

10

Drugs in development for management of lipoprotein disorders.

Brown WV, Bays H, Davidson M, Goldberg A. Brown WV, et al. J Clin Lipidol. 2011 Mar-Apr;5(2):66-75. doi: 10.1016/j.jacl.2011.01.004. Epub 2011 Jan 28. J Clin Lipidol. 2011. PMID: 21392719 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

335 results

Search Page